Camp4 Therapeutics Corp
CAMP- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001736730
In the last 90 days, Camp4 Therapeutics Corp insiders filed 5 open-market purchases and 4 sales; 61 institutions reported holding it in 13F filings for Q2 2026, worth $182.2M in total; no superinvestor holds it.
13F holders, Q1 2025
Institutional positions in Camp4 Therapeutics Corp as of Mar 31, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 39
- +3 vs. Q4 2024
- Shares held
- 12.7M
- −176.6K (−1.4%) vs. Q4 2024
- Total value
- $50.7M
- −$16.4M (−24.4%) vs. Q4 2024
- New holders
- 7
- 11 more added
- Sold out
- 4
- 11 more reduced
Compare with Q4 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting CAMP on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 61 | $182.2M |
| Q1 2026 | 46 | $175.5M |
| Q4 2025 | 40 | $234.6M |
| Q3 2025 | 29 | $84.6M |
| Q2 2025 | 29 | $17.0M |
| Q1 2025 | 39 | $50.7M |
| Q4 2024 | 36 | $67.1M |
| Q3 2024 | 0 | $0 |
| Q2 2024 | 0 | $0 |
| Q1 2024 | 0 | $0 |
| Q4 2023 | 0 | $0 |
| Q3 2023 | 0 | $0 |
| Q2 2023 | 0 | $0 |
| Q1 2023 | 0 | $0 |
| Q4 2022 | 0 | $0 |
| Q3 2022 | 0 | $0 |
| Q2 2022 | 0 | $0 |
| Q1 2022 | 0 | $0 |
| Q4 2021 | 0 | $0 |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q1 2025
Shares, value and share of portfolio for each institution holding Camp4 Therapeutics Corp; share changes are against Q4 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| EverSource Wealth Advisors, LLC | 16 | $64 | 0.00% | +16 | New |
| Sterling Capital Management LLC | 71 | $284 | 0.00% | −41−36.6% | Reduced |
| BNP Paribas Arbitrage, SA | 212 | $848 | 0.00% | −326−60.6% | Reduced |
| Nisa Investment Advisors, LLC | 220 | $880 | 0.00% | +220 | New |
| Amalgamated Bank | 235 | $1.00K | 0.00% | 00.0% | Unchanged |
| CWM, LLC | 260 | $1.00K | 0.00% | +260 | New |
| Royal Bank of Canada | 420 | $2.00K | 0.00% | −84−16.7% | Reduced |
| Boston Private Wealth LLC | 500 | $2.00K | 0.00% | +500 | New |
| California State Teachers Retirement System | 542 | $2.17K | 0.00% | 00.0% | Unchanged |
| Legal & General Group Plc | 708 | $2.81K | 0.00% | 00.0% | Unchanged |
| Ameritas Investment Partners, Inc. | 720 | $2.88K | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 3,183 | $12.7K | 0.00% | −7,125−69.1% | Reduced |
| Bank of America Corp | 3,264 | $13.1K | 0.00% | −13,195−80.2% | Reduced |
| Corebridge Financial, Inc. | 3,487 | $13.9K | 0.00% | +64+1.9% | Added |
| Wells Fargo & Company | 3,781 | $15.1K | 0.00% | +205+5.7% | Added |
| Mirae Asset Global ETFs Holdings Ltd. | 3,786 | $15.1K | 0.00% | +156+4.3% | Added |
| Deutsche Bank AG | 4,643 | $18.6K | 0.00% | +4,643 | New |
| Citigroup Inc | 5,008 | $20.0K | 0.00% | −432−7.9% | Reduced |
| Rhumbline Advisers | 5,820 | $23.3K | 0.00% | −43,969−88.3% | Reduced |
| New York State Common Retirement Fund | 6,600 | $26.4K | 0.00% | +6,600 | New |
| Barclays PLC | 7,508 | $30.0K | 0.00% | −3,162−29.6% | Reduced |
| JPMorgan Chase & Co | 8,243 | $33.0K | 0.00% | −13,029−61.2% | Reduced |
| Morgan Stanley | 8,972 | $35.9K | 0.00% | −5,289−37.1% | Reduced |
| Goldman Sachs Group Inc | 11,955 | $47.8K | 0.00% | −5,535−31.6% | Reduced |
| Bank of New York Mellon Corp | 13,118 | $52.5K | 0.00% | +13,118 | New |
| Charles Schwab Investment Management Inc | 16,685 | $66.7K | 0.00% | 00.0% | Unchanged |
| State Street Corp | 26,236 | $104.9K | 0.00% | +5,736+28.0% | Added |
| Northern Trust Corp | 56,939 | $227.8K | 0.00% | +5,079+9.8% | Added |
| Victory Capital Management Inc | 81,730 | $326.9K | 0.00% | +19,430+31.2% | Added |
| Geode Capital Management, LLC | 159,602 | $638.4K | 0.00% | +14,516+10.0% | Added |
| Alyeska Investment Group, L.P. | 200,000 | $800.0K | 0.00% | 00.0% | Unchanged |
| Vanguard Group Inc | 233,833 | $935.3K | 0.00% | +45,917+24.4% | Added |
| BlackRock, Inc. | 296,216 | $1.18M | 0.00% | +30,846+11.6% | Added |
| Franklin Resources Inc | 635,054 | $2.54M | 0.00% | +540.0% | Added |
| FMR LLC | 766,947 | $3.07M | 0.00% | +11,922+1.6% | Added |
| HarbourVest Partners LLC | 1,271,948 | $5.09M | 3.31% | 00.0% | Unchanged |
| AH Capital Management, L.L.C. | 2,125,339 | $8.50M | 1.21% | 00.0% | Unchanged |
| 5AM Venture Management, LLC | 2,927,915 | $11.7M | 4.43% | 00.0% | Unchanged |
| Enavate Sciences GP, LLC | 3,785,802 | $15.1M | 11.41% | 00.0% | Unchanged |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −200,000−100.0% | Sold out |
| Norges Bank | 0 | $0 | 0.00% | −35,000−100.0% | Sold out |
| Sandia Investment Management LP | 0 | $0 | 0.00% | −5,000−100.0% | Sold out |
| Tower Research Capital LLC (TRC) | 0 | $0 | 0.00% | −3,680−100.0% | Sold out |